Clinical Trial Update: Apathy in Dementia Methylphenidate Trial 2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on methylphenidate for apathy in Alzheimer's disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Apathy

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Apathy, Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-06-13